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Summary.-Lymphocyte transformation with phytohaemagglutinin (PHA) was
studied in 30 patients with immunoproliferative disorders (lymphoproliferative and
plasma cell disorders).
Lymphocyte transformation at 3 days was reduced in the lymphoproliferative
disorders (chronic lymphocytic leukaemia (CLL), well-differentiated (lymphocytic)
follicular lymphoma (FLL) and Waldenstrom's macroglobulinaemia (WM)), and
normal in the plasma cell disorders (myelomatosis, primary systemic amyloidosis,
a-chain disease and benign monoclonal gammopathy) and in idiopathic cold
haemagglutinin disease. A case of plasma-cell leukaemia with increased numbers
of abnormal cells in the circulation also showed reduced transformation. It is sug-
gested that the presence in the circulation of abnormal lymphocytes (or plasma cells)
accounts for the results in CLL and FLL, WM and plasma-cell leukaemia. In WM
a correlation was found between the activity of the disease (expressed by the levels
of IgM paraprotein) and the degree of blast transformation.
The long-term (28 days) in vitro survival of lymphocytes using subconcentrations
of PHA was also studied in 7 patients. The cell populations (PHA-non-responsive)
of CLL and FLL, but not of WM, had a good in vitro survival, resembling in this
respect the normal PHA-responsive population of lymphocytes, but they remained
PHA-non-responsive after 4 weeks' culture. It is speculated that in CLL the long
survival in vitro of the PHA-non-responsive (leukaemic) population corresponds to
their long life-span in vivo.
THE in vitro lymphocyte response to
specific or non-specific mitogens has been
used as a measure of the ability of the
lymphocyte to proliferate and as a reflec-
tion of its immunological function in vivo
(Thomson, 1968; Ling, 1968; Roitt et al.,
1969). Immunological abnormalities are
among the main features of the immuno-
proliferative disorders, a heterogeneous
group which includes the lymphoproli-
ferative and plasma-cell disorders
(Dameshek, 1970).
These neoplastic proliferations of one
or more of the cellular components of the
immunological system have been shown
to have several features in common,
namely: (1) the proliferation of cells
concerned in immunological responses;
(2) immunodeficiences due to defective
synthesis of antibodies, defective cell-
mediated (delayed) hypersensitivity or
both (Miller, 1962; Good et al., 1962;
Fahey et al., 1963; Cone and Uhr, 1964;
Aisenberg, 1968); (3) the production of
monoclonal immunoglobulins (" M " com-
ponents) which is a feature of myelo-
matosis and Waldenstrom's macroglo-
bulinaemia as well as of many cases of
chronic lymphocytic leukaemia (CLL)
and well differentiated (diffuse or folli-
cular) lymphocytic lymphoma (Haller,
1966; Krauss and Sokal, 1966) and of
cases of mixed lymphoid and plasma cell
proliferation (Saunders et al., 1969); and
(4) the well-recognized existence of cases
with features intermediate between two
or more of the diseases in the group
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and Krey, 1968; Zlotnick and Robinson,
1970; Galton et al., 1968; Forte et al.,
1970; Jaeger and Lapp, 1970; Naidu and
Rosner, 1971).
An abnormal lymphocyte population,
non-responsive or slowly responsive to
mitogens, has been demonstrated in
chronic lymphocytic leukaemia (CLL)
(Quaglino and Cowling, 1964; Oppenheim
et at., 1965; Thomson et al., 1966; Schrek,
1967; Lawler et al., 1968; Rubin et al.,
1969). In CLL the percentage of blast
transformation in response to phyto-
haemagglutinin (PHA) correlates inverse-
ly with the total lymphocyte count
(Hayhoe et al., 1967); thus the in vitro
response to PHA may not represent a true
immunological deficiency. Little is known
about lymphocyte function in the other
immunoproliferative disorders, especially
myelomatosis. We examined the in vitro
response of the blood lymphocytes to
PHA in myelomatosis and other immuno-
proliferative disorders. Phytohaemag-
glutinin was chosen because its effect
does not depend on the presence of
antibody receptors on the cell surface.
PATIENTS AND METHODS
Lymphocyte cultures were set up with
cells obtained from 30 patients. The diag-
noses were as follows: Chronic lymphocytic
leukaemia (CLL), 7 cases; well-differentiated
(lymphocytic) follicular lymphoma (FLL),
4; Waldenstrom's macroglobulinaemia
(WM), 6; myelomatosis (MM), 6; and
miscellaneous (MISC), 7 cases which included
2 of idiopathic cold haemagglutinin disease
and one case each of the following: primary
systemic amyloidosis, benign monoclonal
gammopathy, oz-chain disease, and plasma-
cell leukaemia. The cultures were set up
usually before treatment was begun; only 4
of the patients (2 CLL and 2 WM) had been
treated 3 to 14 months previously. Blood
samples from 20 healthy persons were used as
controls.
Peripheral lymphocyte counts were in the
normal range in the cases of MM, MW and
MISC, with the exception of the case of
plasma-cell leukaemia in which the leucocyte
count was 30,000/jul and almost all the cells
were intermediate between small lympho-
cytes and plasma cells; peripheral lymphocyte
counts were also raised (15,00O0/il) in 2 cases
of FLL and in all those of CLL (range
10,000 to 85,000/sl).
Leucocyte suspension cultures were set
up in triplicate in bijoux bottles (Catovsky
and Holt, 1970), in tissue medium TC 199
(Glaxo) containing 20% plasma of known
cultural characteristics; triplicate cultures
containing autologous plasma were also set
up in parallel. All cultures contained 3 x 106
lymphocytes in 3 ml of culture medium;
lymphocytes were not further separated from
the other leucocytes. Short-term cultures
were incubated with a mitogenic dose of
phytohaemagglutinin (PHA, Welleome) for
3 days. In addition, cultures from 3 cases of
CLL, 4 of MM, 3 of WM, and 12 controls were
stimulated with Pokeweed mitogen (Grand
Island) for 3 days. Long-term cultures were
set up simultaneously in 3 cases of CLL, 2 of
FLL, and 2 of WM and in 10 normal controls.
They also contained 3 x 106 lymphocytes at
the beginning of culture and were maintainied
for 28 days, receiving fresh medium and
PHA in a 1/30 dilution of the optimum
mitogenic dose at weekly intervals; PHA at
the mitogenic concentration was added on the
28th day (Naspitz and Richter, 1967;
Catovsky and Holt, 1970).
Lymphocyte transformation was assessed
both morphologically by the percentage of
blast cells, 1000 cells being counted (Penty-
cross, 1968), and by 3H-thymidine incorpora-
tion during DNA synthesis measured in a
liquid scintillation counter (Holt et al., 1966).
Counts per minute (c.p.m.) of radioactivity
represent the activity of the total number of
transformed cells in each culture. In the
long-term cultures the same principle was
applied, making it possible to assess the total
number of transformed cells in both types of
culture by comparing the incorporation of
3H-thymidine added 24 hours before the end
of each culture. Autoradiography by means
of a dipping emulsion technique (Kopriwa
and Leblond, 1962) was performed in some
cases. Immunoglobulin estimations in all
the patients were made by Professor J. R.
Hobbs.
RESULTS
Short-term cultures
The percentages of blast cells in the
3-day PHA cultures are given in Fig. 1.D. CATOVSKY, P. J. L. HOLT AND D. A. G. GALTON
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Fia. 1.-Percentage of transformation in response
to PHA in immunoproliferative disorders-CLL,
chronic lymphocytic leukaemia; FLL, well-differ-
entiated (lymphocytic) follicular lymphoma; WM,
Waldenstrom's macroglobulinaemia; MM, myelo-
atosis; MISC, miscellaneous.
Blast transformation was belowthenormal
range in all 7 cases of CLL and was below
10% in 4; it was also below the normal
range in all 4 cases of FLL and in 4 out of
6 cases of WM. In contrast, all the MM
had normal percentages of blast cells.
The 3H-thymidine incorporation results
are given in Fig. 2; 6 cases were not studied
by this method. These results were in
general similar to those obtained by
counting the percentage of blast cells.
In one case of CLL, one of the FLL, and
one of WM the 3H-thymidine uptake was
in the normal range although the per-
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FIG. 2.-3H-thymidine incorporation in response to
PHA in immunoproliferative disorders. Abbre-
viations as in Fig. 1.
centage ot mlast cells was iow. tio-
thymidine incorporation was normal in
rmaJ MM and MISC, except in the case of
frols plasma-cell leukaemia.
53.3+2SD Fig. 3 relates the percentage of blast
transformation to the serum concentration
of IgM (" M " levels) in the 6 cases of
WM. Two patients in remission had no
detectable paraprotein and their per-
centage blast transformation was only
moderately reduced; an untreated patient
had low " M " levels and normal lympho-
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FIG. 3.-Blast transformation (%) in 6 cases of
Waldenstrom's macroglobulinaemia; correlation
with the levels of IgM paraprotein. Broken line
joins the data in one case studied twice.
patients had increased serum " M " levels
and their cultures showed reduced per-
centages of blast cells. Furthermore, one
of the patients was studied again after a
6-month interval when paraprotein was
not detectable, blast transformation was
only moderately reduced; when the serum
contained 1-5 g% of " M " protein, the
percentage ofblasts in the culture was less
than 3% (Fig. 3, broken line). The results
were similar whether normal or auto-
logous plasma was added to the cultures.
In order to exclude a possible inhibitory
effect of macroglobulinaemic plasma,
simultaneous cultures were set up with
normal lymphocytes in the presence of
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WM plasma. No such effect was demon-
strated with 5 of the WM plasmas. One
exception was the plasma of a WM
patient whose serum concentration of
IgM was 2-2 g%, which caused a 40%
reduction in 3H-thymidine incorporation.
Pokeweed mitogen produced blast
transformation in 15 to 38% of normal
lymphocytes (approximately half the
number transformed with PHA). The
c.p.m. after incubation with 3H-thymidine
were also reduced accordingly. In the
10 cases studied with this mitogen, a
similar reduction in blast transformation
and 3H-thymidine incorporation was ob-
served, which was proportional to the
results obtained in each case with PHA.
Two cases of MM, however, showed a
proportionally lower transformation with
Pokeweed mitogen as expected by com-
parison with the results obtained with
PHA.
Long-term culturem
The proportion of transformed lym-
phocytes in the cultures of normal cells
after long-term culture was higher than in
70
the short-term cultures started simulta-
neously (Fig. 4) (Catovsky and Holt,
1970); these cells incorporated 3H-thymi-
dine and were labelled in autoradiographs.
The total number of lymphocytes which
transform after long-term culture seems
to be similar to that in short-term culture,
as judged by 3H-thymidine incorporation
(Fig. 5). Hence, there is a reduction in
the number of non-transforming lympho-
cytes which accounts for the reduction in
lymphocytes during the long-term culture
(Catovsky and Holt, 1970).
Comparisons of blast transformation
between short- and long-term culture are
seen in Fig. 4 and 5. No major differences
were seen in CLL and FLL in the degree
of blast transformation when assessed
either morphologically or by 3H-thymi-
dine incorporation. In contrast, in
WM the percentage of blast cells after
long-term culture increased to normal
levels which were twice that observed in
short-term culture. Hence, in CLL and in
FLL it seems that the total number of
lymphocytes whichtransformedafterlong-
term culture has remained constant, but
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FIG. 4.-Blast transformation (%) in 7 cases and 9 normals (average of triplicate cultures).
Comparison between results in short and long-term cultures in the same patient.
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FIG. 6.-Autoradiography from a long-term culture (31 days). Blast cells labelled with
3H-thymidine (1000 x ) in a normal control.
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because the percentage of transformed
cells did not increase as in the controls it
is reasonable to assume that the non-
transforming population has also survived
well in these long-term cultures. In fact,
numerous non-transformed lymphocytes
were seen in the long-term culture cyto-
logical preparations and in the auto-
radiographs which showed labelling only
inthelargetransformed cells. In contrast,
autoradiographs from long-term normal
controls showed predominantly labelled
blast cells (Fig. 6). On the other hand,
the survival in vitro of the non-trans-
forming lymphocytes of WM seems to be
reduced and in addition an increase in the
number ofPHA-transformed lymphocytes
was seen in one of the cases.
DISCUSSION
We have studied the capacity of
peripheral blood lymphocytes in myelo-
matosis, Waldenstrom's macroglobuli-
naemia, chronic lymphocytic leukaemia,
follicular lymphocytic lymphoma, and
other immunoproliferative disorders to
transform in vitro under the mitogenic
stimulation of phytohaemagglutinin. It
was tempting to try to correlate the well-
known immunological deficiencies of
these disorders with the results of the
lymphocyte transformation in vitro. Such
a correlation, however, does not seem to
exist. Diseases with increased numbers
of lymphocytes in the circulation which
are part of the neoplastic process, as in
CLL and some FLL, have reduced
lymphocyte transformation when stimu-
lated with PHA. Antibodyformation and
the concentration of normal immuno-
globulins are equally deficient in MM and
CLL (Fahey et al., 1963; Cone and Uhr,
1964), but in our studies lymphocyte
transformation was abnormal only in
CLL. Conversely, cell-mediated (delayed)
hypersensitivity, which is normal early in
the evolution of CLL (Bernadou et al.,
1971) and in MM (Cone and Uhr, 1964;
Aisenberg, 1968), does not correlate well
with our lymphocyte transformation find-
ings. A lack of correlation between
delayed hypersensitivity and lymphocyte
transformation with PHA in CLL was
also demonstrated by Bernadou et al.
(1971). The reduced lymphocyte trans-
formation in CLL is the result of the
presence in the circulation of an abnormal
and slowly reacting population of leukae-
mic lymphocytes (Rubin et al., 1969)
which dilutes the normal population of
lymphocytes in tissue culture, rather than
a reflection ofthe immunological status of
the disease which depends upon the
absolute numbers ofimmunologically com-
petent cells available. A normal (PHA-
responding) population of lymphocytes is
present in CLL patients (Thomson et al.,
1966), butis dilutedbythelargeleukaemic
cell population even though their absolute
numbers seem to be preserved (Oppen-
heim et al., 1965; Hayhoe et al., 1967;
Heine et al., 1969). This has also been
demonstrated by the normalization of the
lymphocyte transformation index after
courses ofsplenic ortotal bodyirradiation,
which selectively destroys the leukaemic
(PHA non-responding) cells (Astaldi et al.,
1966; Kagan andJohnson, 1967; Peckham
and Parmentier, 1968).
Our results also suggest that a popula-
tion of abnormal lymphocytes is present
in the circulation of patients with FLL
and WM. In both there is a relative
increase of lymphocytes which do not
respond to PHA in a normal manner.
The absolute number of these non-
responsive cells was increased in 2 FLL
cases. Similar results have been obtained
in patients with well-differentiated lym-
phocytic lymphomas (Quaglino and
Cowling, 1964; Lawler et al., 1968; Rubin
et al., 1969; Papac, 1970; Liknaitzky et al.,
1970). These cells appear to be analogous
to the non-transforming cells of CLL.
Salmon and Fudenberg (1969) have also
reported abnormal DNA synthesis of
lymphocytes from WM patients. We
have demonstrated, in the latter disease,
an inverse correlation between IgM para-
protein (a measure of the activity of the
disease) and the degree of lymphocyteD. CATOVSKY, P. J. L. HOLT AND D. A. G. GALTON
transformation (Fig. 3). This would
support the findings ofForbes and Lawton
(1969) that circulating lymphocytes from
WM patients are actively involved in the
synthesis of the IgM paraprotein, and
hence that they are part of the disease-
process and are abnormal in character.
Lymphocyte transformation was nor-
mal in 2 cases of cold haemagglutinin
disease. This disease resembles in many
respects Waldenstrom's macroglobuli-
naemia (Schubothe, 1967; Dacie and
Worlledge, 1969), but differs, according
to our findings, in having a normally
PHA-responsive circulating population of
lymphocytes. This difference could be
related to the fact that in WM peripheral
blood lymphocytes participate in the
synthesis of the IgM paraprotein (Forbes
and Lawton, 1969), whereas in cold
haemagglutinin disease only the bone
marrow plasma cells have been shown to
produce the monoclonal cold haemag-
glutinins (Schubothe, 1967).
Lymphocytes from patients with
plasma cell disorders have not been as
extensively studied as those in the
lymphoproliferative disorders. Diseases
of this group included in our study were
MM, primary systemic amyloidosis, oc-
chain disease, and benign monoclonal
gammopathy (Osserman andFahey, 1968).
All of them had normal lymphocyte
transformation when stimulated with
PHA and when measured by morpho-
logical or radioactive methods. Normal
lymphocyte transformation has also
beenreported in other cases ofamyloidosis
(Lehner et al., 1970). Myelomatosis cases,
studied by Salmon and Fudenberg (1969),
were found to have a reduced response to
PHA when assessed for their ability to
synthesize DNA. The difference between
their results and ours could be accounted
for by the use of different methods of
assessing DNA synthesis. The only ab-
normalities found in the MM cases were a
moderately reduced transformation with
Pokeweed mitogen in 2 out of 4 cases, and
a significant increase in binucleated blast-
cells after 3-day stimulation with PHA.
This latter finding is reported in detail
elsewhere (Catovsky et al., 1972).
The evidence for the existence of two
distinctpopulations oflymphocytes, based
on experimental work, has been recently
reviewed by Roitt et al. (1969). This
concept postulates the existence of T-type
(thymic-dependent) and B-type (thymic-
independent) lymphocytes. Blast-cell
transformation by PHA affects almost
exclusively T-lymphocytes (Davies et al.,
1968). The interpretation of reduced
blast-cell transformation in CLL, FLL,
and WM in the light of this concept could
be as follows: (a) an increased number of
B-lymphocytes (if they are part of the
neoplastic process); (b) an increased
number of T-lymphocytes provided they
are functionally " abnormal " because of
their leukaemic character; or (c) a dimi-
nished number of T-lymphocytes and
hence a relative increase of B-lympho-
cytes. In previous experiments (Catovsky
and Holt, 1970) we have shown that the
PHA-responsive population of lympho-
cytes (T-type) survives better than the
PHA-non-responsive one (B-type) in long-
term lymphocyte culturewhen maintained
withdilutePHAorwhen a puresuspension
of lymphocytes (without macrophages) is
used. The PHA-non-responsive normal
lymphocytesseem to bereducedinnumber
after long-term culture and this is why
the relative proportion of blast cells after
PHA-transformation increases when com-
pared with the same cells in a short-term
culture (Fig. 4 and 6).
In WM the reduced transformation
could be the result of a relative excess of
lymphocytes of the B-type, because this
PHA-non-responsive population dimi-
nishes in size during prolonged culture.
The suggestion that the circulating lym-
phocytes in WM are involved in the
disease-process and take part in the
synthesis of the abnormal IgM protein
(Forbes and Lawton, 1969) would support
the concept of excess B-lymphocytes in
this disease; B-cells can differentiate and
proliferate into antibody-producing cells
(Roitt et al., 1969).
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Our results suggest that the PHA-
responsive lymphocytes in cases of lym-
phoproliferative disorders (CLL, FLL, and
WM) can also be maintained for 4 weeks in
culture. However, in CLL and FLL
neither the size of the PHA-responsive
population, measured bythe 3H-thymidine
incorporation (Fig. 5), nor their relative
proportion, measured by the percentage
of blast cells (Fig. 4 and 6), changed
substantially during the long-term culture,
suggesting that in these conditions the
PHA-non-responsive (abnormal?) cells
have also survived well in culture, thus
resembling the T-type in respect to in
vitro survival.
WNre do not know whether the in vitro
culturesurvival ofthedifferentpopulations
of lymphocytes reflects their different
survival in vivo. If this is true, the
PHA-responsive population would corres-
pond to the long-lived lymphocytes
(Everett et al., 1964; Roitt et al., 1969) and
the PHA-non-responsive one to the short-
lived ones. Our observations in CLL
suggest that this may be so. Leukaemic
lymphocytes are known to have a long
life-span in vivo (Hamilton, 1959;
Christensen and Ottensen, 1955) and
accumulate without participating in the
immunological responses; this constitutes
the basis for the theories about the patho-
genesis of this disease (Galton, 1966;
Dameshek, 1967). Our results in long-
term culture of CLL suggest that the
leukaemic cell population has an increased
in vitro survival, thus resembling in this
respect the normal PHA-responsive popu-
lation; however, they are not able to
transform in 3 days after stimulation with
PHA. The data of Rubin et al. (1969)
suggest that they do so in 5 or 6 days,
thus also supporting the concept that the
abnormal CLL cells correspond in the
normal with the PHA-responsive popula-
tion of lymphocytes. However, this view
is not supported by the findings of Wilson
and Nossal (1971) and those of Papami-
chail et al. (1971), who have demonstrated
immunoglobulins on the surface of CLL
lymphocytes which resembled the findings
in the B-lymphocytes. Thus, the question
of the B or T nature of these cells is still
open (Catovsky and Holt, 1971). In the
3 CLL cases studied with Pokeweed
mitogen, which is a more selective B-
lymphocyte stimulant (Janossy and
Greaves, 1971), we could not demonstrate
differences in the 3-day transformation
rate as compared with that ofPHA. Itis,
therefore, obvious that the CLL lympho-
cyte is a grossly abnormal cell which
appears to have lost the recognition site
on its surface (Vincent and Gunz, 1970),
and whose surface layer is thicker than
that of normal lymphocytes. This could
explain its reduced and delayed response
to PHA (Holt et al., 1972).
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